Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2953339rdf:typepubmed:Citationlld:pubmed
pubmed-article:2953339lifeskim:mentionsumls-concept:C0007600lld:lifeskim
pubmed-article:2953339lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:2953339lifeskim:mentionsumls-concept:C0011065lld:lifeskim
pubmed-article:2953339lifeskim:mentionsumls-concept:C0021798lld:lifeskim
pubmed-article:2953339lifeskim:mentionsumls-concept:C0028027lld:lifeskim
pubmed-article:2953339lifeskim:mentionsumls-concept:C2745900lld:lifeskim
pubmed-article:2953339lifeskim:mentionsumls-concept:C1708528lld:lifeskim
pubmed-article:2953339lifeskim:mentionsumls-concept:C0047215lld:lifeskim
pubmed-article:2953339pubmed:issue2lld:pubmed
pubmed-article:2953339pubmed:dateCreated1987-6-11lld:pubmed
pubmed-article:2953339pubmed:abstractTextAdriamycin caused significant interphase death in HL-60 cells during six hours of incubation, which was abolished by the poly(ADP-ribose) polymerase inhibitors, 3-aminobenzamide or nicotinamide. Neither agent changed adriamycin uptake by HL-60 cells. Although 3-aminobenzamide did not alter the number of DNA strand breaks caused by adriamycin, it prevented adriamycin-induced depletion of intracellular NAD+ and ATP, and maintained energy charge. These findings suggest that the activation of poly(ADP-ribose) synthesis plays an important role in the adriamycin-induced interphase death of proliferating HL-60 cells.lld:pubmed
pubmed-article:2953339pubmed:languageenglld:pubmed
pubmed-article:2953339pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2953339pubmed:citationSubsetIMlld:pubmed
pubmed-article:2953339pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2953339pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2953339pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2953339pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2953339pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2953339pubmed:statusMEDLINElld:pubmed
pubmed-article:2953339pubmed:monthAprlld:pubmed
pubmed-article:2953339pubmed:issn0006-291Xlld:pubmed
pubmed-article:2953339pubmed:authorpubmed-author:KubotaMMlld:pubmed
pubmed-article:2953339pubmed:authorpubmed-author:MikawaHHlld:pubmed
pubmed-article:2953339pubmed:authorpubmed-author:AkiyamaYYlld:pubmed
pubmed-article:2953339pubmed:authorpubmed-author:SetoSSlld:pubmed
pubmed-article:2953339pubmed:authorpubmed-author:TakimotoTTlld:pubmed
pubmed-article:2953339pubmed:authorpubmed-author:TanizawaAAlld:pubmed
pubmed-article:2953339pubmed:authorpubmed-author:KiriyamaYYlld:pubmed
pubmed-article:2953339pubmed:issnTypePrintlld:pubmed
pubmed-article:2953339pubmed:day29lld:pubmed
pubmed-article:2953339pubmed:volume144lld:pubmed
pubmed-article:2953339pubmed:ownerNLMlld:pubmed
pubmed-article:2953339pubmed:authorsCompleteYlld:pubmed
pubmed-article:2953339pubmed:pagination1031-6lld:pubmed
pubmed-article:2953339pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:2953339pubmed:meshHeadingpubmed-meshheading:2953339-...lld:pubmed
pubmed-article:2953339pubmed:meshHeadingpubmed-meshheading:2953339-...lld:pubmed
pubmed-article:2953339pubmed:meshHeadingpubmed-meshheading:2953339-...lld:pubmed
pubmed-article:2953339pubmed:meshHeadingpubmed-meshheading:2953339-...lld:pubmed
pubmed-article:2953339pubmed:meshHeadingpubmed-meshheading:2953339-...lld:pubmed
pubmed-article:2953339pubmed:meshHeadingpubmed-meshheading:2953339-...lld:pubmed
pubmed-article:2953339pubmed:meshHeadingpubmed-meshheading:2953339-...lld:pubmed
pubmed-article:2953339pubmed:meshHeadingpubmed-meshheading:2953339-...lld:pubmed
pubmed-article:2953339pubmed:meshHeadingpubmed-meshheading:2953339-...lld:pubmed
pubmed-article:2953339pubmed:meshHeadingpubmed-meshheading:2953339-...lld:pubmed
pubmed-article:2953339pubmed:meshHeadingpubmed-meshheading:2953339-...lld:pubmed
pubmed-article:2953339pubmed:year1987lld:pubmed
pubmed-article:2953339pubmed:articleTitlePrevention of adriamycin-induced interphase death by 3-aminobenzamide and nicotinamide in a human promyelocytic leukemia cell line.lld:pubmed
pubmed-article:2953339pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2953339lld:pubmed